Onconetix, Inc. (ONCO)
1.03
+0.12
(+13.07%)
USD |
NASDAQ |
Sep 25, 16:00
1.06
+0.03
(+2.91%)
After-Hours: 19:59
Onconetix Free Cash Flow : -10.31M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.31M |
| March 31, 2026 | -9.800M |
| December 31, 2025 | -9.678M |
| September 30, 2025 | -7.909M |
| June 30, 2025 | -5.880M |
| March 31, 2025 | -7.687M |
| December 31, 2024 | -10.92M |
| September 30, 2024 | -7.835M |
| Date | Value |
|---|---|
| June 30, 2024 | -9.778M |
| March 31, 2024 | -14.42M |
| December 31, 2023 | -13.64M |
| September 30, 2023 | -18.21M |
| June 30, 2023 | -16.94M |
| March 31, 2023 | -12.26M |
| December 31, 2022 | -8.708M |
| September 30, 2022 | -6.583M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vistagen Therapeutics, Inc. | -62.38M |
| BridgeBio Pharma, Inc. | -437.79M |
| Aprea Therapeutics, Inc. | -12.31M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.918M |
| Cash from Financing (Quarterly) | 4.168M |
| Free Cash Flow Per Share (Quarterly) | -0.8552 |
| Free Cash Flow to Equity (Quarterly) | -1.815M |
| Free Cash Flow to Firm (Quarterly) | -1.914M |
| Free Cash Flow Yield | -1.69K% |